Mannatech (NASDAQ:MTEX) Now Covered by StockNews.com

Analysts at StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued on Friday. The brokerage set a “buy” rating on the stock.

Mannatech Price Performance

Shares of NASDAQ MTEX opened at $7.52 on Friday. The firm has a 50-day simple moving average of $7.58 and a 200-day simple moving average of $7.57. The stock has a market capitalization of $14.14 million, a price-to-earnings ratio of -11.94 and a beta of 1.17. The company has a quick ratio of 0.62, a current ratio of 1.17 and a debt-to-equity ratio of 0.54. Mannatech has a 52 week low of $6.75 and a 52 week high of $10.51.

Mannatech (NASDAQ:MTEX) last issued its earnings results on Tuesday, August 13th. The company reported ($0.33) EPS for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%. The business had revenue of $27.74 million during the quarter.

Insider Buying and Selling

In related news, Director Larry A. Jobe sold 16,288 shares of the firm’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $7.75, for a total transaction of $126,232.00. Following the completion of the sale, the director now directly owns 54,721 shares in the company, valued at approximately $424,087.75. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 41.50% of the stock is owned by company insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.